">

Our Impact

Success Stories

Turi

Turi is a machine learning and AI startup acquired by Apple last August. The company began as an open-source project at Carnegie Mellon in 2009 under Carlos Guestrin’s guidance. In 2012, he joined the University of Washington’s Department of Computer Science & Engineering (now known as the Paul G. Allen School of Computer Science & Engineering) when Amazon founder Jeff Bezos provided $2 million to endow two professorships in machine learning at the UW for Guestrin and his wife, Emily Fox. Guestrin later spun off the open-source project from the UW into its own company. As he developed his startup, it joined CoMotion Labs where we supported its growth through our various programs. The recent $1,000,000 endowed professorship in AI and machine learning by Guestrin to the UW is a great example of how our investments in startups come back full circle to the UW.

PvP Biologics

The company was officially founded in 2012, but we were able to stay at the university and incubate. I want to sincerely thank CoMotion for all their hard work in getting our license through.
— Ingrid Swanson Pultz, PvP Biologics

PvP Biologics is a UW spinout that is developing an oral enzyme for the treatment of celiac disease which affects an estimated 2.4 million Americans. The technology was invented over the course of five years by Ingrid Swanson and David Baker at the University of Washington’s Institute for Protein Design. They recently announced a $35 million agreement with Takeda Pharmaceutical to advance its therapy for the disease. Located continuously in CoMotion Labs, PvP Biologics is giving back through their contribution to the economic development of Washington state.

VICIS

We benefitted from the great energy and vibrancy by headquartering our company at the University of Washington in its early stage. This is just the start as the broader business community is only now becoming aware of how many great ideas there are and how much support is available and how much higher the likelihood is of success if you take an idea from the University and create a company out of it.
— Dave Marver, CEO of Vicis

VICIS: Impact Reducing Football Helmets. VICIS is a UW spinout company that has developed the ZERO 1, a highly-engineered revolutionary helmet technology designed to reduce impact forces. It is based on technology initially developed by mechanical engineering faculty Per Reinhall and Jonathan Posner, neurosurgery faculty member Sam Browd and led by entrepreneur Dave Marver. It is the culmination of a 3-year, $40M research and development effort shaped by some of the world’s leading athletes, engineers, and neurosurgeons. Learn more about VICIS and ZERO 1: http://vicis.co/